These included the following: TUBB6, associated with ‘activation of invasion and metastasis’ and ‘tumour promoting inflammation’; PAK6, linked to ‘sustaining proliferative signaling’, ‘cell death resistance’, ‘activation of invasion and metastasis’, ‘evading growth suppressors’ and ‘immune destruction’; SULT1A1, linked to ‘genomic instability and mutation’, and SLC11A1, associated to ‘resistance to cell death’ (Figure 8B). The gene discussed is SULT1A1; the disease is neoplasm.